De-identified Data from the PArTNER Study: A Pragmatic Clinical Trial to Improve Patient Experience During Transitions from Hospital to Home

The PArTNER study was a single-center pragmatic randomized clinical trial conducted at a minority-serving hospital in Chicago. It evaluated whether a Navigator intervention—delivered by community health workers and peer coaches—could improve patient experience, health outcomes, and healthcare utilization during the transition from hospital to home among adults hospitalized with heart failure, pneumonia, myocardial infarction (MI), chronic obstructive pulmonary disease (COPD), or sickle cell disease. A total of 1,029 adults, predominantly non-Hispanic Black, participated. The intervention included in-hospital visits, a home visit, and follow-up telephone coaching. The primary outcomes were changes in anxiety and informational support at 30 days post-discharge. The study found no significant overall improvements compared to usual care, although exploratory analyses suggested potential benefits for certain subgroups.<b>Data Description:</b><br>The dataset includes de-identified information on participant demographics, clinical characteristics, social determinants of health, Patient-Reported Outcomes Measurement Information System (PROMIS) scores (e.g., anxiety, informational support), healthcare utilization outcomes (e.g., hospital readmissions, emergency department visits), and intervention engagement. Data were collected through baseline hospital assessments, telephone follow-up surveys at 30 and 60 days post-discharge, and electronic health record reviews.<br><b>Publications related to data:</b>LaBedz, Stephanie L., et al. "Pragmatic clinical trial to improve patient experience among adults during transitions from hospital to home: the PArTNER study." Journal of general internal medicine 37.16 (2022): 4103-4111.Prieto-Centurion, Valentin, et al. "Design of the patient navigator to Reduce Readmissions (PArTNER) study: a pragmatic clinical effectiveness trial." contemporary clinical trials communications 15 (2019): 100420.